Table 3.
Number and percentage of subjects by HbA1c before and after the EVLCD.
| N (%) | HbA1c After |
||||
|---|---|---|---|---|---|
| <7 (mg/dL) | 7–8 (mg/dL) | 8–9 (mg/dL) | >9 (mg/dL) | ||
| HbA1c Before | <7 (mg/dL) | 4 (12.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| 7–8 (mg/dL) | 6 (18.2) | 5 (15.2) | 0 (0.0) | 0 (0.0) | |
| 8–9 (mg/dL) | 6 (18.2) | 5 (15.2) | 0 (0.0) | 0 (0.0) | |
| >9 (mg/dL) | 3 (9.1) | 3 (9.1) | 1 (3.0) | 0 (0.0) | |
Table cells with subjects having the same, lower or higher HbA1c levels after EVLCD compared to before EVLCD are filled in dark gray, light gray and white, respectively. Total number of subjects = 33.